Human TGM6 ELISA Kit (V2LY-0626-LY45)
Basic Information
- Pre-coated plate: 12 wells * 8 detachable strips
- Positive control: 0.5ml x 1 vial
- Negative control: 0.5ml x 1 vial
- HRP conjugated: 6ml x 1 vial
- Sample diluent: 6ml x 1 vial
- Substrate solution A: 6ml x1 vial
- Substrate solution B: 6ml x1 vial
- Stop solution: 6ml x1 vial
- Wash buffer (25x): 20ml x 1 vial
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA35 patients commonly show upper limb involvement and torticollis. There is no cognitive impairment.
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon
Submit a review
Loading...
Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us
